Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05323682
Other study ID # IMIB SIM
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date January 1, 2020
Est. completion date August 30, 2022

Study information

Verified date April 2022
Source Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
Contact Salvador Ibañez-Mico, MD
Phone 34968369647
Email salvador.ibanez@carm.es
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Pediatric epilepsy has been described as an age related-condition, and it has a strong impact on childhood quality of life. Psychological symptoms and self-esteem impairment are common facts. Although there are some studies studying the benefits of physical exercise in order to improve seizure control in adults with epilepsy, we have not found studies that support it in pediatric population. Few studieshave reported in childhood some benefits in terms of quality of life, self-esteem and improvement of neuropsychological symptoms. Therefore, it is necessary to use a validated and applicable scale of quality of life in children with epilepsy. Otherwise, findings may be difficult to reproduce


Recruitment information / eligibility

Status Recruiting
Enrollment 24
Est. completion date August 30, 2022
Est. primary completion date January 1, 2021
Accepts healthy volunteers No
Gender All
Age group 5 Years to 18 Years
Eligibility Inclusion Criteria: 1. Age 5-14 years 2. Diagnosis of epilepsy (must meet at least one of the following criteria): 1. At least 2 unprovoked seizures in a period of more than 24 hours 2. A seizure and probability of future seizures similar to the general risk of recurrence (60% or more) than if the patient had had 2 crises. 3. Diagnosis of epileptic syndrome. 3. Adequate communication skills with your family. 4. Absence of significant motor limitation. 5. Parents or legal guardians must have given consent to participate in the study. Exclusion Criteria: b) Exclusion criteria: 1. Failure to meet any of the aforementioned requirements. 2. Failure to complete completely and/or legibly any of the instruments of evaluation. c) Abandonment criteria 1. Failure to deliver the submitted questionnaires in a timely manner. 2. Failure to attend the scheduled appointment to complete the questionnaires control. 3. Not responding to phone calls, e-mails or requests made to make a new appointment.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Individualized physical exercise program
An individualized physical exercise program was programmed, monitored remotely by e-mail or the use of an activity wristband
NO Individualized physical exercise program
Usual medication

Locations

Country Name City State
Spain Hospital Clínico Universitario Virgen de la Arrixaca Murcia

Sponsors (1)

Lead Sponsor Collaborator
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary PedsQL (Pediatric Quality of Life Inventory) Likert scale 0-5 Up to 6 months
Primary (Quality of Life in Childhood Epilepsy Questionary, QoLCE) 16 items version Up to 6 months
Primary PAQ-C (Physical Activity Questionnaire) Likert scale 0-5 Up to 6 months
Primary BMI (Body mass index) (kg)/height (m2) Up to 6 months
Primary Waist/hip ratio ICC= w/h (cm) Up to 6 months
Primary Tricipital skinfold Thickness of the skinfold located over the triceps muscle Up to 6 months
Primary Subscapular skinfold Thickness of localized adipose tissue immediately below the inferior angle of the scapula Up to 6 months
Primary Lower extremity strength Standing Long Jump Test Up to 6 months
Primary Grip strength Takei Tkk 5401 Digital Hand Dynamometer below the inferior angle of the scapula Up to 6 months
Primary Cardiorespiratory fitness. It was carried out with the Course Navette test (round trip 20 meters) Up to 6 months
See also
  Status Clinical Trial Phase
Recruiting NCT06202976 - Mapping Epileptic Networks Using Multimodal Imaging
Recruiting NCT04770337 - Pivotal-Safety and Therapeutic Measures of tDCS in Patients With Refractory Focal Epilepsy N/A
Recruiting NCT05885646 - Effect of Sulthiame on EEG in Childhood Epilepsy Syndromes
Completed NCT04545346 - The Potential of a Low Glutamate Diet as a Treatment for Pediatric Epilepsy N/A
Completed NCT06400966 - The Effect of Jigsaw Technique on Childhood Epileptic Seizure Management Knowledge and Attitudes of Nursing Students N/A
Not yet recruiting NCT06388577 - The Effect of the Training Programme Based on the Health Promotion Model Given to Parents N/A
Not yet recruiting NCT06402526 - Evaluating the Efficacy of a Mobile Epilepsy Education Application N/A
Terminated NCT04639310 - XEN496 (Ezogabine) in Children With KCNQ2 Developmental and Epileptic Encephalopathy Phase 3
Recruiting NCT06444126 - The Incidence And Risk Factors Of Recurrent Febrile Seizures And Epilepsy Following Febrile Seizures
Withdrawn NCT04308252 - Comparison of Microbiome Composition and Biomarkers in Pharmaco Resistant and Pharmaco-Sensitive Epilepsy
Recruiting NCT06300814 - The Effect of Exercise and Music on Sleep, Quality of Life and Emotional State in Children With Epilepsy N/A
Active, not recruiting NCT03916848 - Novel Network Analysis of Intracranial Stereoelectroencephalography N/A
Recruiting NCT05439876 - Getting SMART for Pediatric Epilepsy Phase 2/Phase 3
Not yet recruiting NCT06455384 - The Genetics Navigator: Evaluating a Digital Platform for Genomics Health Services N/A
Recruiting NCT04584385 - Advanced EEG Technology in Childhood Epilepsy
Not yet recruiting NCT04219930 - Nucleotide Protein -3 in Epileptic Children
Completed NCT04020484 - Making Mindfulness Matter© in Children With Epilepsy N/A
Recruiting NCT06093490 - Detecting Absence Seizures Using Hyperventilation and Eye Movement Recordings
Completed NCT05675254 - The Prevalence and Risk Factors of Coagulopathy in Pediatric Epilepsy Surgery Patients
Recruiting NCT05740423 - Standardization of Anti-Seizure Medications Withdrawals After Seizure Remission in Young Patients With Epilepsy